Clinical Trial

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Study acronym: PERFORM
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma
Trial Details
NCT Number NCT06372496
Lead Sponsor GlaxoSmithKline
Conditions Asthma
Enrollment 1,366 participants
Start Date 2024-04-16
Primary Completion 2025-07-28 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-24